Department of Surgery, Stanford School of Medicine, VA Palo Alto Health Care System, 3801 Miranda Avenue, GS 112, Palo Alto, CA, 94304, USA.
Department of Surgery, Center for Metabolic and Bariatric Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.
Obes Surg. 2023 Jan;33(1):3-14. doi: 10.1007/s11695-022-06332-1.
MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m, regardless of presence, absence, or severity of co-morbidities.MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m.BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m suggests clinical obesity, and individuals with BMI >27.5 kg/m should be offered MBS.Long-term results of MBS consistently demonstrate safety and efficacy.Appropriately selected children and adolescents should be considered for MBS.(Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.
1991 年美国国立卫生研究院减重手术指南的重大更新：代谢和减重手术（MBS）推荐用于体重指数（BMI）>35 kg/m²的个体，无论是否存在合并症及其严重程度如何。对于代谢疾病且 BMI 为 30-34.9 kg/m²的个体，应考虑进行 MBS。应调整亚洲人群的 BMI 阈值，使 BMI>25 kg/m²提示临床肥胖，而 BMI>27.5 kg/m²的个体应提供 MBS。MBS 的长期结果始终显示出安全性和有效性。应考虑对适当选择的儿童和青少年进行 MBS。（Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ）©2022 年美国代谢与减重外科学会。保留所有权利。
